DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 894 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $362,000 | -40.5% | 2,742 | -58.2% | 1.31% | +526.3% |
Q4 2017 | $608,000 | +102.0% | 6,553 | +86.7% | 0.21% | +143.0% |
Q3 2017 | $301,000 | -95.0% | 3,509 | -95.0% | 0.09% | -91.2% |
Q1 2017 | $6,023,000 | +209.8% | 70,421 | +182.0% | 0.98% | +369.7% |
Q4 2016 | $1,944,000 | -48.5% | 24,968 | -48.2% | 0.21% | -57.3% |
Q3 2016 | $3,777,000 | +125.6% | 48,184 | +190.7% | 0.49% | +148.5% |
Q2 2016 | $1,674,000 | +330.3% | 16,573 | +304.2% | 0.20% | +35.2% |
Q1 2016 | $389,000 | -66.3% | 4,100 | -69.6% | 0.14% | -50.7% |
Q2 2015 | $1,155,000 | +164.3% | 13,500 | +162.2% | 0.29% | +87.3% |
Q1 2015 | $437,000 | +58.9% | 5,149 | +60.7% | 0.16% | +8.3% |
Q4 2014 | $275,000 | -59.9% | 3,204 | -63.2% | 0.14% | -24.9% |
Q2 2014 | $685,000 | +54.6% | 8,700 | +47.2% | 0.19% | +34.0% |
Q1 2014 | $443,000 | – | 5,909 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |